Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years

Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years

Upworthy

Published

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 13.21% on an annualized basis producing an average annual return of 28.0%. Currently, Krystal Biotech has a market capitalization of $4.13 billion. Buying $100 In KRYS: If ... Full story available on Benzinga.com

Full Article